Center for Drug Discovery and Innovation
News updates for the Center of Excellence, Drug Discovery & Innovation at USF.
USF's Center for Drug Discovery and Innovation (CDDI) transitioned to a new leadership
October 3, 2017
On July 1, 2017, USF's Center for Drug Discovery and Innovation (CDDI) transitioned to a new leadership team. We are pleased to announce that Dr. Randy Larsen, Associate Dean for the Office of Research and Scholarship in the College of Arts & Sciences, and Dr. Stephen Liggett, Vice Dean for Research at the Morsani College of Medicine and USF Health's Associate Vice President for Research, have agreed to serve as co-directors of this vital USF System resource.
USF-led study sheds light on how malaria parasites grow exponentially
March 3, 2015
Findings may lead to new treatment to curb threat of drug-resistant malaria.
CDDI's Dr. Wade Borcherds, Dr. Stepan Kashtanov and Dr. Gary Daughdrill's recent paper
July 23, 2013
Structural divergence is more extensive than sequence divergence for a family of intrinsically disordered proteins.
Computer-Controlled Micromachining Instrument for Custom Fabrication
CDDI Focus on Technology: Computer-Controlled Machining Instrument for Custom Fabrication.
Dr. Gary Daughdrill coauthor on new article in Intrinsically Disordered Proteins
April 1, 2013
The alphabet of intrinsic disorder I. Act like a Pro: On the abundance and roles of proline residues in intrinsically disordered proteins.
Discovery of a Splicing Regulator Required for Cell Cycle Progression
February 21, 2013
CDDI's Dr. Elena Suvorova's latest article on the novel splicing factor that was identified in Toxoplasma gondii. Deficiency in this factor led to immediate arrest of the parasite in early G1 phase due to severe mis-splicing of virtually all cellular transcripts.